GOLDMAN SACHS GROUP INC - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 67 filers reported holding FORTRESS BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q3 2023$711,155
+693.4%
163,484
+0.3%
0.00%
Q2 2023$89,629
-34.7%
162,961
-2.6%
0.00%
Q1 2023$137,202
+27.7%
167,320
+2.0%
0.00%
Q4 2022$107,418
-23.8%
163,997
+0.2%
0.00%
Q3 2022$141,000
-10.2%
163,647
-12.3%
0.00%
Q2 2022$157,000
-54.4%
186,618
-26.2%
0.00%
Q1 2022$344,000
-40.6%
252,976
+9.3%
0.00%
Q4 2021$579,000
-23.5%
231,487
-1.5%
0.00%
Q3 2021$757,000
+13.0%
234,923
+25.1%
0.00%
Q2 2021$670,000
-15.8%
187,782
-16.8%
0.00%
Q1 2021$796,000
+101.0%
225,654
+80.4%
0.00%
Q4 2020$396,000
-36.7%
125,060
-19.3%
0.00%
Q3 2020$626,000
+103.9%
155,047
-4.6%
0.00%
Q1 2020$307,000
+207.0%
162,482
+318.6%
0.00%
Q4 2019$100,000
+212.5%
38,815
+79.8%
0.00%
Q2 2019$32,000
+33.3%
21,588
+57.1%
0.00%
Q1 2019$24,000
-25.0%
13,738
+29.8%
0.00%
Q2 2018$32,000
-31.9%
10,581
-10.3%
0.00%
Q4 2017$47,000
-13.0%
11,797
-2.9%
0.00%
Q3 2017$54,000
-15.6%
12,147
-43.9%
0.00%
Q3 2016$64,000
-91.3%
21,647
-92.0%
0.00%
Q2 2016$732,000
+311.2%
272,189
+373.0%
0.00%
Q1 2016$178,000
+423.5%
57,548
+369.1%
0.00%
Q4 2015$34,000
-45.2%
12,268
-48.8%
0.00%
Q3 2015$62,000
-83.8%
23,947
-79.0%
0.00%
Q2 2015$382,000113,8330.00%
Other shareholders
FORTRESS BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 3,887,500$12,323,0001.61%
Nantahala Capital Management 8,680,909$27,518,0000.85%
SHIKIAR ASSET MANAGEMENT INC 558,500$1,770,0000.64%
CPWM, LLC 506,267$1,605,0000.15%
Sandbox Financial Partners, LLC 14,650$46,0000.04%
Sepio Capital, LP 134,748$427,0000.04%
683 Capital Management, LLC 200,000$635,0000.03%
GSA CAPITAL PARTNERS LLP 22,928$73,0000.01%
Virtu Financial LLC 33,333$106,0000.01%
B. Riley Wealth Advisors, Inc. 55,510$176,0000.01%
View complete list of FORTRESS BIOTECH INC shareholders